CY1108425T1 - Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης - Google Patents

Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης

Info

Publication number
CY1108425T1
CY1108425T1 CY20081101158T CY081101158T CY1108425T1 CY 1108425 T1 CY1108425 T1 CY 1108425T1 CY 20081101158 T CY20081101158 T CY 20081101158T CY 081101158 T CY081101158 T CY 081101158T CY 1108425 T1 CY1108425 T1 CY 1108425T1
Authority
CY
Cyprus
Prior art keywords
treatment
phaxoxic
cystic
surgery
acid producers
Prior art date
Application number
CY20081101158T
Other languages
Greek (el)
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108425(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical Co., Ltd. filed Critical Kissei Pharmaceutical Co., Ltd.
Publication of CY1108425T1 publication Critical patent/CY1108425T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20081101158T 2003-05-05 2008-10-16 Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης CY1108425T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
EP04722967A EP1620085B1 (en) 2003-05-05 2004-03-24 Use of phenoxyacetic acid derivatives for treating hyperactive bladder

Publications (1)

Publication Number Publication Date
CY1108425T1 true CY1108425T1 (el) 2014-04-09

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101158T CY1108425T1 (el) 2003-05-05 2008-10-16 Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης

Country Status (26)

Country Link
US (1) US20040229947A1 (https=)
EP (1) EP1620085B1 (https=)
JP (1) JP4602969B2 (https=)
KR (1) KR101052804B1 (https=)
AR (1) AR044169A1 (https=)
AT (1) ATE401878T1 (https=)
AU (1) AU2004236596B2 (https=)
BR (1) BRPI0409980A (https=)
CA (1) CA2524023C (https=)
CL (1) CL2004000952A1 (https=)
CY (1) CY1108425T1 (https=)
DE (1) DE602004015272D1 (https=)
DK (1) DK1620085T3 (https=)
ES (1) ES2309513T3 (https=)
IL (1) IL171713A (https=)
MX (1) MXPA05011862A (https=)
MY (1) MY141756A (https=)
NZ (1) NZ543347A (https=)
PE (1) PE20050524A1 (https=)
PL (1) PL1620085T3 (https=)
PT (1) PT1620085E (https=)
RU (1) RU2342133C2 (https=)
SI (1) SI1620085T1 (https=)
TW (1) TWI351279B (https=)
UY (1) UY28306A1 (https=)
WO (1) WO2004098586A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
WO2006118087A1 (ja) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. ヒドロキシノルエフェドリン誘導体塩酸塩・１／４水和物の結晶
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP3634420A1 (en) 2017-06-06 2020-04-15 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60041110D1 (de) * 1999-11-01 2009-01-29 Sumitomo Chemical Co 6-Hydroxy-5,6-dihydrouracile als Herbizide
UA77000C2 (en) * 2001-09-13 2006-10-16 Kissei Pharmaceutical Crystalline form of hydroxynorephedrine derivative

Also Published As

Publication number Publication date
IL171713A (en) 2011-12-29
TWI351279B (en) 2011-11-01
CA2524023C (en) 2011-11-22
BRPI0409980A (pt) 2006-05-09
KR20060009886A (ko) 2006-02-01
RU2005137701A (ru) 2006-06-10
NZ543347A (en) 2008-05-30
EP1620085B1 (en) 2008-07-23
RU2342133C2 (ru) 2008-12-27
MY141756A (en) 2010-06-30
WO2004098586A1 (en) 2004-11-18
EP1620085A1 (en) 2006-02-01
UY28306A1 (es) 2004-12-31
AU2004236596A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
MXPA05011862A (es) 2006-02-17
AR044169A1 (es) 2005-08-24
US20040229947A1 (en) 2004-11-18
JP2006525318A (ja) 2006-11-09
KR101052804B1 (ko) 2011-07-29
DK1620085T3 (da) 2008-11-24
ATE401878T1 (de) 2008-08-15
PT1620085E (pt) 2008-08-07
JP4602969B2 (ja) 2010-12-22
CA2524023A1 (en) 2004-11-18
SI1620085T1 (sl) 2008-12-31
ES2309513T3 (es) 2008-12-16
PL1620085T3 (pl) 2009-01-30
CL2004000952A1 (es) 2005-03-04
TW200509902A (en) 2005-03-16
AU2004236596B2 (en) 2010-03-11
DE602004015272D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
CY1109728T1 (el) Νεα παραγωγα υδαντοϊνης για τη θεραπεια αποφρακτικων νοσηματων της αναπνευστικης οδου
CY1115870T1 (el) Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για μη νοηματικη καταστολη και τη θεραπεια ασθενειας
EA200601584A1 (ru) Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
NO20082496L (no) Pyrazinderivater
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1108425T1 (el) Χρηση παραγωγων φαινοξυοξικου οξεος στην αντιμετωπιση της υπερλειτουργικης ουροδοχου κυστης
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER